IMMUCELL CORP /DE/ (ICCC) › Operating IncomeIMMUCELL CORP /DE/ (ICCC) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$529.9K2010: -$690.3K2011: -$632.7K2012: $245.0K2013: -$19.6K2014: -$206.4K2015: $2.12M2016: $890.2K2017: -$242.8K2018: -$1.45M2019: -$953.9K2020: -$1.38M2021: $257.4K2022: -$2.30M2023: -$5.75M2024: -$1.64M2025: $1.65M$1.65M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$1.65M+200.6%2024-$1.64M+71.5%2023-$5.75M-150.0%2022-$2.30M-993.2%2021$257.4K+118.6%2020-$1.38M-44.7%2019-$953.9K+34.1%2018-$1.45M-495.7%2017-$242.8K-127.3%2016$890.2K-58.1%2015$2.12M+1128.3%2014-$206.4K-955.6%2013-$19.6K-108.0%2012$245.0K+138.7%2011-$632.7K+8.3%2010-$690.3K-30.3%2009-$529.9K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share